PharmaEngine (4162)

Currency in TWD
74.40
+0.30(+0.40%)
Closed·
4162 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
73.0075.00
52 wk Range
72.30123.00
Key Statistics
Bid/Ask
66.50 / 66.60
Prev. Close
96.2
Open
74.7
Day's Range
73-75
52 wk Range
72.3-123
Volume
885.02K
Average Volume (3m)
581.86K
1-Year Change
-19.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4162 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

PharmaEngine Company Profile

PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

Compare 4162 to Peers and Sector

Metrics to compare
4162
Peers
Sector
Relationship
P/E Ratio
6.0x−24.0x−0.5x
PEG Ratio
0.010.020.00
Price/Book
1.9x2.7x2.6x
Price / LTM Sales
4.2x29.7x3.3x
Upside (Analyst Target)
61.3%0.0%45.4%
Fair Value Upside
Unlock−13.6%7.7%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 12.33%
Dividend Yield
8.06%
Industry Median 0.97%
Annualised payout
6.00
Paid annually
5-Years Growth
+64.38%
Growth Streak

Earnings

Latest Release
Jul 29, 2025
EPS / Forecast
0.69 / 0.69
Revenue / Forecast
224.00M / 224.00M
EPS Revisions
Last 90 days

4162 Income Statement

FAQ

What Stock Exchange Does PharmaEngine Trade On?

PharmaEngine is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for PharmaEngine?

The stock symbol for PharmaEngine is "4162."

What Is the PharmaEngine Market Cap?

As of today, PharmaEngine market cap is 10.69B.

What Is PharmaEngine's Earnings Per Share (TTM)?

The PharmaEngine EPS (TTM) is 12.33.

When Is the Next PharmaEngine Earnings Date?

PharmaEngine will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is 4162 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PharmaEngine Stock Split?

PharmaEngine has split 3 times.

How Many Employees Does PharmaEngine Have?

PharmaEngine has 44 employees.

What is the current trading status of PharmaEngine (4162)?

As of 03 Aug 2025, PharmaEngine (4162) is trading at a price of 74.40, with a previous close of 96.20. The stock has fluctuated within a day range of 73.00 to 75.00, while its 52-week range spans from 72.30 to 123.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.